Instructions to Authors
Important New Changes
The journal now encourages authors to complete their license-to-publish form online. It takes only a couple of clicks.
Authors who are NIH-funded have their papers automatically deposited in PubMed Central.
NO page charge is required for Molecular Plant authors, excluding optional color printing costs.
Molecular Plant has implemented a strict limit on the length of articles. All articles should not exceed 8000 words in the main text (excluding the title page, references, figure legends, and tables).
For the initial submission, figure legends should be placed below the corresponding figure, as well as in the main text. The main text and all figures (with the legends) are converted into a single PDF for uploading to the submission site. Supplemental materials should be submitted separately, as a single PDF.
Starting from 2013, Molecular Plant will publish a short summary of 2-3 sentences for each Research and Review Article in the online Table of Contents (underneath the title and list of authors). Once a manuscript is accepted, authors will provide a short summary of no more than 400 characters (including spaces) to highlight the findings. This short summary should not merely repeat what is already in the title and abstract. It is meant to pinpoint the broad significance of the findings understood by a general audience. Please use a subtitle "short summary" and place it at the bottom of the title page (before the abstract) in the "source file" requested by editorial staff.Aims and Scope
Presubmission and Status Inquiries
Nomenclature and Terminology
Fees and Charges
Licence to Publish
Open Access Option for Authors
Aims and Scope
Molecular Plant is an international journal publishing significant findings in plant biology, focusing broadly on cellular biology, physiology, biochemistry, molecular biology, genetics, development, plant-microbe interaction, genomics, bioinformatics and molecular evolution.
In addition to full papers with novel insights of high impact, we also encourage submissions of original research that is highly novel but not fully developed. Contributions may comprise Research Articles, Review Articles and Editorials as well as the article types listed below.
Fast-track papers report ground-breaking and time-sensitive discoveries and will be reviewed by the Editorial Board within 2 weeks of submission, with publication online within two weeks of receipt of the final manuscript by Oxford University Press.
Method Development is a short (maximum of 8 printed pages) paper describing the development of new methods likely to be broadly utilized by the molecular plant science community. Papers reporting new methods or techniques should provide a significant application of the method.
Spotlight is a commentary/highlight style of paper, particularly focusing on emerging topics and cutting edge researches in plant biology. Papers discussing new ideas/hypothese of braod interest to the plant science community are also welcome. Spotlight papers will be no more than 1200 words (2–3 print pages) with a maximum of one figure/table/diagram and up to 10 references.
Letters to the Editor report novel findings that have an immediate impact on current plant biological research. They should have no more than one figure, 1500 words text, and 10 references. All Letters to the Editor are expected to undergo fast peer review and rapid publication.
Presubmission and Status Inquires
Authors who would like to get feedback from Molecular Plant about whether their manuscript is suitable for publication in the journal can send a letter of presubmission inquiry. For Research or Review Article presubmission inquiry, please provide the significance statement of your study or review as well as the title, author information, abstract and key figures of your manuscript. For Letter to the Editor or Spotlight paper presubmission inquiry, please supply the full paper.
All correspondence should be sent to Molecular Plant editorial office at email@example.com.
Once submitted, the manuscript will be moved into the status of “Under Review” soon, until a decision is made. Authors who would like to know more information about the status of their submitted manuscript can send an inquiry to firstname.lastname@example.org
Before initiating the submission process, the instructions below should be read carefully to ensure that the article complies with Molecular Plant standards and format. Even if authors have previously read them, it is strongly recommended that these pages should be re-read in their entirety, as they are updated periodically.
Authors should submit manuscripts online at http://submit.mplant.oxfordjournals.org/. The Bench>Press submission system will prompt authors through the process. Help is also available from http://submit.mplant.oxfordjournals.org/submission/submissionhelp and from the editorial office (Tel: +86 21-54922858 or +1 415 338-6193; E-mail: email@example.com). For the initial submission, Figure Legend should be placed below the corresponding figure as well as in the main text. The main text and all figures (with the legends) can be converted into a single complete PDF for uploading. Supplemental materials should be submitted as a single PDF separately. For manuscript re-submission, a manuscript file in Microsoft Word (or some other word processing form) is required and will be automatically converted to a PDF by the Bench>Press submission system. Although there are no file size limitations, note that large files will take longer to upload and convert to PDF depending on the Internet connection. Please try to keep the maximum combined PDF file size to less than 5 MB.
Manuscripts submitted to Molecular Plant should be accompanied by a cover letter. The cover letter should clearly state the novelty and significance of the work being submitted as well as how it advances our understanding of plant biology. If authors are submitting a manuscript to be considered for a themed special issue, this should be stated in the cover letter. Excluded reviewers and conflicts of interest may be indicated in the cover letter.
Authors should select at least two potential Editors and provide names of up to six potential reviewers for their manuscript. Choice of Editors closest to the field of interest will increase the speed of reviewing. Editors who are at the same institutions as any of the authors should not be selected. Suggested reviewers should not have been advisers, advisees, co-authors or collaborators within the past 3 years.
All persons designated as authors should qualify for authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically for important intellectual content, and must have read and approved the final version of the manuscript. Any other contributors should instead be acknowledged appropriately in the Acknowledgments section. The corresponding author is responsible for ensuring that all authors have made bona fide, substantive contributions to the research and have seen and approved the manuscript in final form prior to submission.
The multiple corresponding authors are allowed for a single submission, while other than in exceptional circumstances the journal does not allow addition or removal of author names after submission. A satisfactory explanation for any proposed changes in authorship will be required. We will also require a letter of consent from any person whose name has been removed indicating that they agree to the removal of their name from the author list.
Manuscripts should follow Molecular Plant style, be written in concise and grammatically correct English, and be presented in a manner and at a level that will be accessible to the broad readership of the journal, not specialists. The use of abbreviations and jargon should be avoided, and terms that are not widely known should be explained clearly at first use.
Consult a current issue of Molecular Plant for guidance on format, organization, and preparation of figures, legends, tables, and references. Manuscripts should be prepared in Microsoft Word (or some other word processing form) with 1.5 line spacing and in 12 point type; use symbol font for Greek characters to avoid inadvertent character substitutions. Please do not use Chinese, Japanese or Korean fonts. Figures should be prepared digitally (see below). Please note that Molecular Plant has implemented a strict limit to the length of articles. All articles should not exceed 8000 words in the main text (excluding the title page, references, figure legends, and tables).
Formats accepted for the manuscript file are Word, WordPerfect, and PDF (Portable Document File). For Word processing files, Times, Times New Roman, Courier, Helvetica and Arial are the recommended fonts; for best quality conversions of special characters and symbols, use the Symbol font. Image and table file formats accepted are GIF, TIFF, EPS and JPEG. For tables, the system also accepts the most common word processing formats. Formats not supported include the following: Bitmap (.bmp), PICT (.pict), Excel (.xls), Photoshop (.psd), Canvas (.cnv), CorelDRAW (.cdr) and locked or encrypted PDFs. Multi-page PowerPoint files (.ppt) are not supported; one slide per file is acceptable.
Organize manuscripts in the following order: Title Page, Abstract (please include several keywords with your submission, this will go under the abstract in the article), Introduction, Results, Discussion, Methods, Acknowledgments, Figure Legends, Tables, and References. Note that when submitting your manuscript the References must be placed at the end of your document file. Tables should be included as part of your manuscript file. Figures and regular Supplementary data (Supplementary text, figures and small tables) should be sent as separate files and not as part of the manuscript. See the sections on Figures and Supplementary Data below for more details.
The title page should include the authors' full names and affiliations, a running title of 50 characters or less (in addition to the full paper title), and the telephone and fax numbers and e-mail address of the corresponding author, who will be designated in the online submission system to be the primary contact with the journal office. Institutional affiliations should correspond to where the work was done, not where the author is at present.
The full manuscript title should be succinct (less than120 characters) and informative. The title should include sufficient detail for indexing but be general enough to be clear to the broad readership of the journal. Toward that end, abbreviations and acronyms, including those for gene and protein names, should be avoided in titles or the general nature of the abbreviated entity should be clear. The journal encourages active titles over merely descriptive ones whenever possible. The title must mention the subject organism (or general group in the case of comparative works). Common names are allowed for major model systems (maize, rice, yeast); scientific names should be used for all organisms that have no widely accepted common name.
The abstract should stand on its own with no reference to the text. It should contain no more than 200 words and must summarize the questions being addressed, the approach taken, the major findings, and the significance of the results. It should not contain discursive matter. The abstract should be concise, complete, and clearly communicate the importance of the work for a broad audience. Please also include several keywords with your submission under the abstract in the article.
The Introduction should provide the necessary background information for the average reader; it should be both complete and concise. Previous publications that form a basis for the work presented must be cited. Citation of reviews is not a substitute for citing primary research articles. Citation of recent research articles is not a substitute for citing original discoveries. An author's own work should not be cited preferentially over equally relevant work of others. Authors' previously published data that are presented along with new data must be identified clearly and cited appropriately; duplicate publication of data (including data previously published as supplementary material) is not allowed without citation.
Results and Discussion
The Results and Discussion can be subdivided if subheadings give the manuscript more clarity. The Discussion should not repeat the Results; instead, the Discussion should explore the implications of the Results, citing relevant published research, and should also be as concise as possible. The Discussion can be combined with the Results if this will render the manuscript more readable.
A Conclusions section is generally not permitted. Statements of priority or first finding are generally not permitted in Molecular Plant.
Methods must be described completely enough that other laboratories can replicate results and verify claims. Generally, standard procedures should be referenced, though significant variations should be described. Appropriate experimental design and statistical methods should be applied and described wherever necessary for proper interpretation of data and verification of claims. All novel materials and the procedures to prepare them should be described in sufficient detail to allow their reproduction (e.g., DNA constructs, genetic stocks, enzyme preparations, and analytical software). Trade names should be capitalized and the manufacturer’s name and website given. Publication in Molecular Plant requires that authors make available all novel materials integral to the reported results for non-commercial research purposes (see Materials Distribution Policy [link 3]). A statement concerning the availability, or restrictions on availability, should be included in the Methods section of the paper; it will be up to referees to decide if any such restrictions are reasonable.
Large-scale experiments. In evaluating large-scale experiments such as transcript profiling, we will consider whether there is a clear and complete description of each experiment; whether biological and/or technical replicates should have been used; what statistical analysis has been performed. Large-scale data sets must be made available for review at the time of submission and must be deposited in an accepted format to a permanent public repository with open access (e.g., GEO http://www.ncbi.nlm.nih.gov or Array-Express http://www.ebi.ac.uk/arrayexpress.
Quantification of molecules, including DNA, RNA, and proteins. Methods for quantification of levels or differences in levels of molecules in biological samples must be described fully and shown to be quantitative and reproducible, using true biological replicates. Any conclusion that levels differ between samples must be supported by presentation of methods and data shown to be reliable; supporting information demonstrating reliability of an assay may sometimes be provided as Supplementary Information rather than in the body of the manuscript, subject to the approval of the handling editor. Use of the term ‘semi-quantitative’ is not acceptable in Molecular Plant; instead, assays must be shown to be sufficiently quantitative to support a conclusion of changes in levels.
Molecular phylogenetic analyses. Methods used for sequence analysis must be reported in full with citations and software and parameter values (even if only default values were used) in a separate section of Methods entitled "Phylogenetic Analysis". Please note that CLUSTAL does not produce an acceptable phylogeny; use a true phylogenetic analysis program (e.g., PHYLIP, MEGA, MR. BAYES). Alignments used to produce phylogenies should be produced with an appropriate alignment program (e.g., CLUSTAL), then manually adjusted to optimize alignments. Alignments must be provided as a Supplementary Table or Figure (preferably as a .doc file). Statistical support for nodes in phylogenetic tree figures must be reported (e.g., posterior probabilities or bootstrap values from a minimum of 1000 trials). Authors are encouraged to consult with an expert in molecular phylogenetics if they do not have such expertise themselves.
Accession numbers. Novel nucleotide and amino acid sequences must be deposited in a public repository such as the GenBank database (http://www.ncbi.nlm.nih.gov/). Accession numbers for genes must be specific for each gene; accession numbers for BAC clones or chromosomes are not acceptable substitutes. In the case of Arabidopsis, the AGI locus identifier ("At number") must be provided for each gene described (see http://www.arabidopsis.org). If a new function or mutation is found to be associated with a previously known DNA sequence (i.e., an existing GenBank entry), authors are encouraged to create a new GenBank entry in order to link the sequence and the gene symbol/function in the database. In the case of (partially or completely) sequenced vectors and constructs, accession numbers should be provided. All data necessary to validate protein structure determinations, including x-ray amplitudes and phases and the derived atomic coordinates, should be submitted to the Protein Data Bank (http://www.rcsb.org/pdb).
Accession numbers should be provided as the last paragraph of Methods (just before Acknowledgements) with the heading "Accession Numbers" for any genes or new sequence data discussed in the article. Insert the following statement and provide accession numbers: "Sequence data from this article can be found in the EMBL/GenBank data libraries under accession number(s) XX000000." In the case of Arabidopsis, the AGI locus identifier ("At number") must be provided for each gene described (see http://www.arabidopsis.org). If a list of accession numbers is provided in a table or figure, that can be stated in this section, rather than listing all of the numbers. Accession numbers must also be provided for any supplementary data that is placed in a permanent public repository (e.g., GEO http://www.ncbi.nlm.nih.gov/geo, Array-Express http://www.ebi.ac.uk/arrayexpress, or Protein Data Bank (http://www.rcsb.org/pdb)). If an accession number has not been assigned at the time of submission, please use Xs as placeholders to be updated later. In general, accession numbers should be provided only in the Methods, not elsewhere in the manuscript, unless needed for clarity.
Supplementary material to be submitted as a single PDF file
We encourage authors to include all necessary data in the manuscript body. If authors must submit supplemental data, all supplemental files should be combined and submitted as a single PDF file entitled Supplemental Information. This merged PDF file will be no larger than 10 MB and can include figures, tables and supplemental methods and references. If large data sets and video files are necessary, they can be submitted as separate files according to the instructions for Supplementary Data Submission.
Note: For the initial submission, figure legend must be placed below the corresponding figure, in addition to its presence in the main text.
Figure legends should be concise and should not repeat information presented in the text. Figure numbers should be given in Arabic numerals and figure parts in upper case letters (eg 1A, 1B).
• all symbols and abbreviations that are used in the figure
• bar graph error bars and sample sizes
• scale, unless already indicated in the picture.
Accession numbers should not be included in figure legends.
A separate typewritten, 1.5 line-spaced list of legends of all figures must be supplied and included in the text file. Please be aware that figure legends are used by search engines for figure searches.
You can download the current reference style for Molecular Plant from EndNote's website (http://endnote.com/downloads/style/molecular-plant).
Cite references in the text by name and date of publication and not by number. List articles that are only published or in press. Cite in the text all unpublished results, including personal communications and submitted manuscripts (for example, R. Goldberg and K. Jofuku, unpublished results). A permission letter from each person cited as a personal communication will be required upon acceptance. Permission is also required from the authors of unpublished information cited in the text if those authors are different from the article's authors. Citations for web sites (other than for primary literature) should be handled parenthetically in the text and not included in the reference list. Authors should test all URLs and links.
It is expected that all cited publications have been read and determined to be appropriate by the authors, not merely identified by database searches. Reference to specific results should be to original research articles, not to more recent articles or reviews.
References should contain complete titles and inclusive page numbers. If you are citing an article that only exists as an online pre-issue version, use the ‘doi’ (unique identifying number) and publication date, as follows:
Author, A.B., and Author, B.B. (2007). Title of article. Molecular Plant Advance Access published March 5, 2003, doi:10.1093/mplant/msg013
The ‘doi’ is the long number typically given at the end of the reference in the online contents.
Authors are expected to proofread every citation in their reference list against the PDF or photocopy of the cited work so that the reference list is accurate with respect to spellings, symbols, italics, subscripts/superscripts, and accents.
Observe the following guidelines to ensure that all readers, reviewers, and editors will be able to comprehend your data:
• Figures should be self-explanatory and should provide enough information to be understood independently from the text.
• In fluorescent double-staining micrographs and DNA chips, use magenta and green instead of red and green.
• For micrographs with triple or more channels, additionally show either a grayscale image of each channel, or the combination of the two most important channels in magenta and green.
• For graphs and line drawings, label elements on the graph itself rather than making a separate color-coded key.
• Do not try to convey information in color only, but use BOTH color and shape (solid and dotted lines, different symbols, various hatchings, etc.; however, avoid pattern fills if creating PowerPoint files). For more information, see the following website: http://jfly.iam.u-tokyo.ac.jp/color/.
For the initial submission, figure legend must be placed below the corresponding figure, in addition to its presence in the main text. All figures with the legends can be converted into a single PDF file together with the main text for uploading in the initial submission. Once your manuscript is accepted, you will be required to supply high-resolution .tif figure files for production in the journal.
For print production, minimum resolutions are 300 d.p.i. for color or tone images, and 1200 d.p.i. for line drawings at approximately the correct size for publication. We advise that you create your high-resolution images first as these can be easily converted into low-resolution images for online submission.
Figures should be sized to fit in a single (max. 8.5 cm or 3.25 inches in width) or double column (max. 17.5 cm or 7.5 inches in width) wherever possible. For gel blots, submit combination figures in which the labels and photographs or autoradiographs are composite images. In general, smaller gel images look neater than larger ones. Format sequence data to occupy one column for shorter sequences and two columns for longer sequences. Images which do not fit within one or double column, will be resized to fit those dimensions at 300 dpi.
When creating figures, please make sure any embedded text is large enough to read. Certain image formats such as .jpg and .gif do not have high resolutions, so you may select to save your figures and insert them as .tif instead. Use the same fonts for all figures. Parts of composite figures should be labeled with capital case letters in bold Arial font. Wording in figures must match the rest of the manuscript for capitalization, italics, and use of symbols.
Color figures should be converted to CMYK (Cyan-Magenta-Yellow-Black). "Adobe (1998)" should be selected as the ICC profile to ensure that we can reproduce the color accurately. RGB figures will be converted to CMYK on receipt, resulting in slight color changes, therefore authors should convert them before submission so that any adjustment in contrast is made at this stage to the author's satisfaction.
Figures will not be re-lettered by the publisher. The journal reserves the right to reduce the size of illustrative material. Any photomicrographs, electron micrographs or radiographs must be of high quality. Wherever possible, photographs should fit within the print area or within a column width. Photomicrographs should provide details of staining technique and a scale bar.
For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da.
Nomenclature and Terminology
Authors are encouraged to follow the widely accepted conventions of nomenclature and terminology of genes and proteins.
Each cover of Molecular Plant features an image representative of an article published in that issue. Authors who wish to have an image considered for the cover should upload the image as an additional supplementary file along with a separate text file that includes a brief one-paragraph description of the image, and indicate on the checklist provided at acceptance that a cover candidate has been submitted. If an author does not hold the copyright for a submitted image, they are responsible for obtaining the necessary permission to use the image in Molecular Plant.
Members of the editorial board will evaluate all manuscripts upon submission to determine whether they are appropriate for evaluation by expert outside reviewers. Decisions will be made as rapidly as possible, and the journal strives to return reviewers' comments to authors within four weeks whenever possible. If revision is requested, the editorial board will evaluate revised manuscripts and determine whether outside review is required. The board normally will consider only one revised manuscript, and this manuscript must be submitted within 1 month for minor revisions and two months for major revisions unless an extension is granted. In the case that extensive revision including additional experimentation is required, journal policy is to decline the manuscript, but editors may choose to encourage resubmission. Resubmissions are subject to the full review process. It is the goal of the journal to send authors a first decision within four weeks of submission and to publish manuscripts online within four weeks of final acceptance, but this can only be achieved if the original submission meets all journal requirements.
Accepted manuscripts are published online at Molecular Plant Advance Access upon receipt of a licence form from the author (see below for details). We aim to publish all accepted manuscripts within one week of acceptance. The 'Accepted Manuscript' is replaced online by the 'Corrected Proof' as soon as the latter is ready.
Accepted manuscripts are copyedited for grammar and journal style before a proof is generated. In an effort to facilitate rapid publication, after authors have reviewed proof and corrections are made, the article will be posted online as part of the publication Molecular Plant Advance Access.
Articles are posted anywhere from a few days to a few weeks prior to the full online issue of the journal. Corrected proofs published at Molecular Plant Advance Access are considered to be final publication: subsequent edits will only be permitted to correct the most serious errors. For more information please see our 'Post-production corrections' policy here.
If an author does not want to have an article posted online ahead of final publication, it should be specified on the checklist provided at acceptance. The official date of publication is the date that the article first appears online as part of Molecular Plant Advance Access.
The journal typesetter will deliver electronic page proofs to the corresponding author. The author will have access to a PDF file, which will contain PDF pages (with figures and tables), a file showing changes made during copyediting, and a reprint order form. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Notes added in proof will be sent to the editor assigned to the manuscript prior to publication and will be reviewed for appropriate content and wording. Authors will receive proofs approximately 3 to 4 weeks after final acceptance of the manuscript. Because of the tight publication schedule, authors must relay all additions and corrections to Oxford Journals by e-mail within 24 hours of receipt of the proofs. Failure to act promptly to approve the page proofs may delay publication of the manuscript.
Fees and Charges
There are no page charges for publishing in Molecular Plant. From January 2012, color figures incur a fee of US$200/£125/€140/RMB¥1300 per figure where the editors agree color is essential for understanding the result presented. One color figure per article will be provided free for reviewers, board members, and invited authors. Authors may also choose to have free online color for their figures if color is not critical for data interpretation but aids in presentation. The print version of the figures will be in black and white. This option can be selected when figures are uploaded during online submission. The use of online-only color will be subject to editorial review to ensure that color is not critical for data interpretation but aids in presentation.
An invoice for the charge will be sent to you by the Editorial Office. Note that if you choose to have your paper open access and/or order offprints you will be invoiced for these separately by Oxford University Press.
The publishers supply the URL upon electronic publication. Printed offprints are avaialble to purchase from the author services licensing site. Late orders submitted after the journal is printed are subject to increased prices.
Author self-archiving/public access policy
For information about this journal's policy, please visit our Author Self-Archiving policy page. It is a condition of publication in the Journal that authors grant an exclusive license to the Institute of Plant Physiology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and the Chinese Society of Plant Biology. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Oxford University Press is notified in writing and in advance.
Conflict of interest
Molecular Plant policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
Molecular Plant is a member of the Committee on Publication Ethics (COPE), and strives to adhere to its code of conduct and guidelines. Authors are encouraged to consult http://publicationethics.org/resources/guidelines for more information.
Materials Distribution Policy
Publication in Molecular Plant implies that the authors agree to provide materials that are integral to the results presented in the article, including whatever would be necessary for a skilled investigator to verify or replicate the claims. Authors are generally expected to take advantage of public repositories or commercial vendors to the extent possible. Authors should refer to the Materials Distribution Policy in these instructions for explanation of the journal's expectations of authors and requestors.
Submission of a manuscript implies that it reports unpublished work, that it is not under consideration for publication elsewhere and that, if accepted, it will not be published elsewhere in the same form, either in English or in any other language, without the consent of the publisher. Authors should provide the references of similar work that they have already published, or which is currently under consideration by another journal. If the work has previously been presented at a conference, authors should provide details in the covering letter. The journal will consider publication of work that has previously been presented as either a short abstract or poster at a conference, but not as a full paper. If previously published tables, illustrations or more than 200 words of text are to be included, then the copyright holder's written permission must be obtained. Include copies of any such permission letters with your paper.
All persons designated as authors should qualify for authorship. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically for important intellectual content, and must have read and approved the final version of the manuscript.
Other than in exceptional circumstances the Journal does not allow addition or removal of author names after submission. A satisfactory explanation for any proposed changes in authorship will be required. We will also require a letter of consent from any person whose name has been removed indicating that they agree to the removal of their name from the author list. Owing to the complexity of these rules we strongly advise authors to fix the author list before submission and not to attempt to make changes later.
Licence to Publish
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form.
Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.
Open Access Option for Authors
Molecular Plant authors have the option to publish their paper under the
Oxford Open articles are published under Creative Commons licences. Authors publishing in Molecular Plant can use the following Creative Commons licences for their articles:
• Creative Commons Attribution licence (CC-BY)
• Creative Commons Non-Commercial licence (CC-BY-NC)
• Creative Commons non-Commercial No Derivatives licence (CC-BY-NC-ND)
Please click here for more information about the Creative Commons licences.
You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The open access charges applicable are:
• Regular charge - £1750 / $2800 / €2275
• List B Developing country charge* - £875 / $1400 / €1138
• List A Developing country charge* - £0 /$0 / €0
*Visit our developing countries page for a list of qualifying countries.
Please note that these charges are in addition to any colour charges that may apply.
Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.
The following rules should be followed:
• The sentence should begin: ‘This work was supported by …’
• The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI' (one of the 27 subinstitutions) or 'NCI at NIH’ (full RIN-approved list of UK funding agencies).
• Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’
• Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
• Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
• Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
An example is given here: ‘This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.] and the Alcohol & Education Research Council [HFY GR667789].
Particularly if English is not your first language, before submitting your manuscript you may wish to have it edited for language. This is not a mandatory step, but may help to ensure that the academic content of your paper is fully understood by journal editors and reviewers. Language editing does not guarantee that your manuscript will be accepted for publication. If you would like information about such services please click here. There are other specialist language editing companies that offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.
- About the journal
- Rights & Permissions
- This journal is a member of the Committee on Publication Ethics (COPE)
- We are mobile – find out more